BORA PHARMACEUTICALS LTD (6472) — Free Cash Flow Generation Index
BORA PHARMACEUTICALS LTD (6472) has a Free Cash Flow Generation Index of 0.63x as of March 2026. Free cash flow of NT$357.38 Million represents 1% of operating cash flow (NT$568.46 Million). Explore BORA PHARMACEUTICALS LTD capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BORA PHARMACEUTICALS LTD Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. For the full cash flow conversion analysis, see 6472 cash flow metrics.
Annual Free Cash Flow Generation for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year Free Cash Flow Generation Index for BORA PHARMACEUTICALS LTD. Check 6472 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | NT$3.31 Billion | NT$4.24 Billion | NT$928.67 Million | ▲ +160.8% |
| 2024 | 0.30x | NT$293.76 Million | NT$980.81 Million | NT$687.05 Million | ▼ -56.6% |
| 2023 | 0.69x | NT$3.18 Billion | NT$4.61 Billion | NT$1.43 Billion | ▼ -23.4% |
| 2022 | 0.90x | NT$1.81 Billion | NT$2.01 Billion | NT$200.22 Million | ▲ +27.5% |
| 2021 | 0.71x | NT$873.05 Million | NT$1.24 Billion | NT$363.58 Million | ▲ +388.4% |
| 2020 | 0.14x | NT$25.70 Million | NT$177.79 Million | NT$152.09 Million | ▲ +107.2% |
| 2019 | -2.01x | NT$-465.56 Million | NT$231.77 Million | NT$697.33 Million | — |